Stockreport

GlycoMimetics' Focus Is On AML Therapy [Seeking Alpha]

GlycoMimetics, Inc.  (GLYC) 
Last glycomimetics, inc. earnings: 5/1 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.glycomimetics.com/investor-relations
PDF SummaryGlycoMimetics is conducting a Phase 3 trial of Uproleselan for acute myeloid leukemia.Cash on hand is sufficient to get to the top-line data release.The company s [Read more]